Aspirin - orphan drug designation in polycythemia vera

被引：0
|
作者：
Zwick, YC
机构：
来源：
THROMBOSIS AND HAEMOSTASIS | 2004年 / 92卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：IX / IX
页数：1
相关论文
共 50 条
  • [1] IS ORPHAN DESIGNATION A DRIVER OF ORPHAN DRUG PRICING?
    Degrassat-Theas, A.
    Paubel, P.
    de Curzon, Parent O.
    Berard, F.
    Poisson, N.
    Le Pen, C.
    Sinegre, M.
    VALUE IN HEALTH, 2012, 15 (07) : A302 - A302
  • [2] Orphan Drug Designation for Qutenza
    不详
    JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (08) : 777 - 777
  • [3] Low-dose aspirin in polycythemia vera
    Dutrillaux, F
    Maynadié, M
    Carli, PM
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16): : 1683 - 1683
  • [4] Worldwide collaboration for orphan drug designation
    Mariz, Segundo
    Reese, James H.
    Westermark, Kerstin
    Greene, Lesley
    Goto, Takahiro
    Hoshino, Tatsuro
    Llinares-Garcia, Jordi
    Sepodes, Bruno
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (06) : 440 - 440
  • [5] RegeneRx receives Orphan Drug designation
    不详
    WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2004, 16 (07): : A22 - +
  • [6] Orphan Drug Designation and PharmacogenomicsOptions and Opportunities
    Paul D. Maher
    Marlene Haffner
    BioDrugs, 2006, 20 : 71 - 79
  • [7] Worldwide collaboration for orphan drug designation
    Segundo Mariz
    James H. Reese
    Kerstin Westermark
    Lesley Greene
    Takahiro Goto
    Tatsuro Hoshino
    Jordi Llinares-Garcia
    Bruno Sepodes
    Nature Reviews Drug Discovery, 2016, 15 : 440 - 441
  • [8] Orphan drug designation for NTZ expanded
    不详
    AIDS PATIENT CARE AND STDS, 1997, 11 (03) : 198 - 198
  • [9] Low-dose aspirin in polycythemia vera - Reply
    Spivak, JL
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16): : 1684 - 1685
  • [10] Drug development challenges in polycythemia vera
    Ritchie, Ellen Kelly
    BLOOD, 2019, 134 (06) : 495 - 496
12345